Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.
- E. Zamagni, F. Patriarca, +14 authors M. Cavo
- Medicine
- Blood
- 1 December 2011
We prospectively analyzed the prognostic relevance of positron emission tomography-computed tomography (PET/CT) at diagnosis, after thalidomide-dexamethasone (TD) induction therapy and double… Expand
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.
- S. Gillessen, G. Attard, +58 authors A. Omlin
- Medicine
- European urology
- 1 February 2018
BACKGROUND
In advanced prostate cancer (APC), successful drug development as well as advances in imaging and molecular characterisation have resulted in multiple areas where there is lack of evidence… Expand
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE
- I. Virgolini, V. Ambrosini, +8 authors A. Chiti
- Medicine
- European Journal of Nuclear Medicine and…
- 2 July 2010
The aim of these guidelines is to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin (SST) receptor PET/CT imaging using… Expand
Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA
- M. Bozkurt, I. Virgolini, +12 authors S. Fanti
- Medicine
- European Journal of Nuclear Medicine and…
- 25 May 2017
Purpose & MethodsNeuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic… Expand
68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
- F. Ceci, C. Uprimny, +10 authors I. Virgolini
- Medicine
- European Journal of Nuclear Medicine and…
- 15 May 2015
PurposeTo assess the association between PSA levels, PSA kinetics and other factors and a pathological 68Ga-PSMA PET/CT scan in patients with recurrent prostate cancer (rPCa) with biochemical relapse… Expand
Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis.
- M. Farsad, R. Schiavina, +12 authors S. Fanti
- Medicine
- Journal of nuclear medicine : official…
- 1 October 2005
UNLABELLED
This study evaluated the potential usefulness of (11)C-choline PET/CT for detection and localization of tumors within the prostate. We used the results of step-section histopathologic… Expand
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in…
- E. Zamagni, C. Nanni, +15 authors M. Cavo
- Medicine
- Haematologica
- 2007
BACKGROUND AND OBJECTIVES
Bone lesions in multiple myeloma (MM) have been traditionally detected by whole body X-ray (WBXR) survey although magnetic resonance imaging (MRI) has become the gold… Expand
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma
- G. Treglia, P. Castaldi, +10 authors V. Rufini
- Medicine
- European Journal of Nuclear Medicine and…
- 6 January 2012
PurposeTo retrospectively evaluate and compare 18F-FDG, 18F-DOPA and 68Ga-somatostatin analogues for PET/CT in patients with residual/recurrent medullary thyroid carcinoma (MTC) suspected on the… Expand
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors
- V. Ambrosini, D. Campana, +7 authors S. Fanti
- Medicine
- Journal of Nuclear Medicine
- 1 May 2010
Several authors reported the superiority of 68Ga-DOTANOC PET/CT to conventional imaging (CI) for the assessment of neuroendocrine tumors (NET). However, the detection of a higher number of lesions is… Expand
New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
- L. Evangelista, A. Briganti, +6 authors M. Picchio
- Medicine
- European urology
- 1 July 2016
CONTEXT
Radiolabelled choline positron emission tomography has changed the management of prostate cancer patients. However, new emerging radiopharmaceutical agents, like radiolabelled prostate… Expand